Sunday, July 20, 2025

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Push for National Bird Flu Vaccine Program as USDA Points to Falling Egg Prices After Gains in Biosecurity Containment

by Carolyn Hendler, JD and Barbara Loe Fisher
chick & shot
Publicity about avian influenza (H5N1) infecting chickens, turkeys and cows in the United States and globally has been widespread for several years ...

Study of First Next Generation mRNA Bird Flu Shots in Cattle Published

by Carolyn Hendler, JD
vaccinating cattle
Researchers at the University of Pennsylvania have published a study based on their experimental use of a next generation mRNA bird flu ...

FDA Approves Yeztugo as Injectable Product to Prevent HIV in Adults and Adolescents

by Rishma Parpia
HIV vaccine
Last week, Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo (lenacapavir), the company’s injectable HIV-1 ...

Clinical Trials Now Required for Annual COVID Shots Given to Healthy Adults

by Amber Baker
doctor and patient
On May 20, 2025, the U.S. Food and Drug Administration (FDA) announced that new clinical trials will be required to approve annual ...

CDC Vaccine Advisory Panel Purged

by Marco Cáceres
woman carrying box
On June 9, 2025, U.S. Secretary of Health and Human Services Robert F. Kennedy, Jr. fired all 17 members of the U.S ...

FDA Approves MenQuadfi Meningococcal Vaccine for Six-Week-Old Infants

by Amber Baker and Barbara Loe Fisher
vaccinating an infant
The U.S. Food and Drug Administration (FDA) has licensed Sanofi’ SA’s four-valent MenQuadfi meningococcal vaccine for use in infants aged six weeks ...

Government Cancels $700 Million in Funding for Moderna’s Bird Flu Biologic

by Natasha Hobley
bird flu vaccine
The U.S. government has cancelled a contract worth over $700 million awarded to Moderna, Inc. for late-stage development of an mRNA bird ...

FDA Licenses Moderna’s mNEXSPIKE COVID Shot for Individuals at High Risk for Severe COVID Disease

by Rishma Parpia
mNEXSPIKE biologic
On May 30, 2025, the U.S. Food and Drug Administration (FDA) licensed mNEXSPIKE (mRNA-1283), a newly developed mRNA COVID-19 biologic for individuals ...

In this section

Search in Archive

Search in Site

To search in site, type your keyword and hit enter

Search
The Vaccine Reaction
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.